Progressive Development of a New Tool for Rapid Thematic Analysis of Community Perceptions and Concerns During Health Emergencies.

Introducing a hybrid intrusion detection method for IoT-cloud environments based on ResNeXt and improved Ebola optimization search algorithm.

Enhancing cyberthreat defense mechanisms using ensemble of representation learning with binary Ebola optimization search in internet of things environment.

Establishing Vitreoretinal Surgery Capacity in Sierra Leone: Challenges and Opportunities to Address Retinal Health Disparities in Resource-limited Settings.

Ebola virus disease sequelae and viral persistence in animal models: Implications for the future.

Exploring equity in global health collaborations: a qualitative study of donor and recipient power dynamics in Liberia.

Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccines.

Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replication.

Detecting changes in the transmission rate of a stochastic epidemic model.

[Tropical sexually transmitted infections Summary of the SFMTSI Scientific Day of November 9, 2023].

Design of universal Ebola virus vaccine candidates via immunofocusing.

Production and Purification of Filovirus Glycoproteins.

Human MARCH1, 2, and 8 block Ebola virus envelope glycoprotein cleavage via targeting furin P domain.

Selective replication and vertical transmission of Ebola virus in experimentally infected Angolan free-tailed bats.

Sustaining Preparedness in Hospitals.

Preparing for another Ebola Outbreak: The impact of viral inactivation methods on commonly measured biochemistry analytes in plasma and urine.

Piloting delivery of PfSPZ vaccines for malaria through a cryogenic vaccine cold chain to travel and military medicine clinics.

RNA binding motif 4 inhibits the replication of ebolavirus by directly targeting 3'-leader region of genomic RNA.

Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection.

Markers of antroponotic viral infections in vervet monkeys arrived from their natural habitat (Tanzania).

A novel feature selection algorithm for identifying hub genes in lung cancer.

Reverse Genetics Systems for Filoviruses.

Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and mice.

Regulation of Ebola GP conformation and membrane binding by the chemical environment of the late endosome.

Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.

The evolution and determinants of neutralization of potent head-binding antibodies against Ebola virus.

Expediting approval for medical countermeasures to address high burden disease: an ethical justification to move beyond emergency use authorisation.

Sequence optimized diagnostic assay for Ebola virus detection.

The inclusion of pregnant women in vaccine clinical trials: An overview of late-stage clinical trials' records between 2018 and 2023.

Supporting the Manufacturing of Medical Supplies in Africa: Collaboration Between Africa CDC, Partners, and Member States.

Effect of Interferon Gamma on Ebola Virus Infection of Primary Kupffer Cells and a Kupffer Cell Line.

Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections.

Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication.

Donning and doffing of personal protective equipment for health care workers in a tertiary hospital in China: A simulation study.

Adipose Tissues from Human and Bat-Derived Cell Lines Support Ebola Virus Infection.

Negative and ambisense RNA virus ribonucleocapsids: more than protective armor.

Learning from implementation of a COVID case management desk guide and training: a pilot study in Sierra Leone.

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.

Ebola Virus Uses Tunneling Nanotubes as an Alternate Route of Dissemination.

Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo.

Depletion of Bone Marrow Hematopoietic Cells in Ebolavirus-Infected Rhesus Macaques: A Possible Cause of Hematologic Abnormalities in Ebolavirus Disease.

Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo.

Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability.

Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo.

Interplay of Ebola Virus With Immune Cells Leading to Their Death by Diverse Mechanisms.

Clinical and Immunologic Correlates of Vasodilatory Shock Among Ebola Virus-Infected Nonhuman Primates in a Critical Care Model.

The Multiple Origins of Ebola Disease Outbreaks.

Automatic detection and classification of lung cancer CT scans based on deep learning and ebola optimization search algorithm.

Contrasting effects of filamin A and B proteins in modulating filovirus entry.

Ebola Virus Infection Induces HCAR2 Expression Leading to Cell Death.

An Antiviral Role for TRIM14 in Ebola Virus Infection.

The Susceptibility of BALB/c Mice to a Mouse-Adapted Ebola Virus Intravaginal Infection.

Atypical Ebola Virus Disease in a Rhesus Macaque.

A Single Case Observation: Is the Ebola Virus Soluble Glycoprotein an Indicator of Viral Recrudescence?

Limited Benefit of Postexposure Prophylaxis With VSV-EBOV in Ebola Virus-Infected Rhesus Macaques.

Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection.

A Single-Dose Intranasal Combination Panebolavirus Vaccine.

Spatial and functional arrangement of Ebola virus polymerase inside phase-separated viral factories.

Ebola Virus Tropism in Ex Vivo Cynomolgus Macaque Ocular Tissues.

The Mucin-Like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets.

Ebola virus disease: A narrative review.

Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona.

[When serology contradicts the experience of the disease: Ethics, research, and announcements about Ebola in Guinea].

Ebola virus inclusion bodies are liquid organelles whose formation is facilitated by nucleoprotein oligomerization.

N6-methyladenosine is required for efficient RNA synthesis of Ebola virus and other haemorrhagic fever viruses.

A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection.

A Pan-Ebolavirus Monoclonal Antibody Cocktail Provides Protection Against Ebola and Sudan Viruses.

The Inability of Marburg Virus to Cause Disease in Ferrets Is Not Solely Linked to the Virus Glycoprotein.

Ebola Virus Disease Features Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in the Rhesus Macaque Model.

COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats.

Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.

Reemergence of Marburgvirus disease: Update on current control and prevention measures and review of the literature.

Ebola virus disease: A review for the emergency medicine clinician.

Single-Dose Treatment With Vesicular Stomatitis Virus-Based Ebola Virus Vaccine Expressing Ebola Virus-Specific Artificial Micro-RNA Does Not Protect Mice From Lethal Disease.

Magnetic Resonance Imaging for Monitoring of Hepatic Disease Induced by Ebola Virus: a Nonhuman Primate Proof-of-Concept Study.

Marburg Virus Disease: Global Threat or Isolated Events?

A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.

Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection.

Development of immortalized rhesus macaque kidney cells supporting infection with a panel of viruses.

Pathogenesis of Aerosolized Ebola Virus Variant Makona in Nonhuman Primates.

Fluorescent and Bioluminescent Reporter Mouse-Adapted Ebola Viruses Maintain Pathogenicity and Can Be Visualized in Vivo.

Structural and Energetic Basis for Differential Binding of Ebola and Marburg Virus Glycoproteins to a Bat-Derived Niemann-Pick C1 Protein.

Development of a Pan-Filoviridae SYBR Green qPCR Assay for Biosurveillance Studies in Bats.

Establishing a Mouse Model for Sexual Transmission and Male Reproductive Tract Persistence of Ebola Virus.

Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.

Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates.

Sphingosine Kinases Promote Ebola Virus Infection and Can Be Targeted to Inhibit Filoviruses, Coronaviruses, and Arenaviruses Using Late Endocytic Trafficking to Enter Cells.

Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes.

N'-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile.

Potential use of the cholesterol transfer inhibitor U18666A as an antiviral drug for research on various viral infections.

Magnetic biosensors for identification of SARS-CoV-2, Influenza, HIV, and Ebola viruses: a review.

Modelling the impact of stigmatisation of Ebola survivors on the disease transmission dynamics.

Ebola virus-like particles reprogram cellular metabolism.

Natural history of nonhuman primates after conjunctival exposure to Ebola virus.

Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19.

Solidarity Against Ebola: an update.

Characterization of an air-liquid interface primary human vaginal epithelium to study Ebola virus infection and testing of antivirals.

Infectious diseases, dividend policy, and independent directors: Evidence from textual analysis.

Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP).

Structure of the Inmazeb cocktail and resistance to Ebola virus escape.

Ebola Virus Activates IRE1α-Dependent XBP1u Splicing.

Inactivation of Ebola Virus and SARS-CoV-2 in Cell Culture Supernatants and Cell Pellets by Gamma Irradiation.

Ebola virus disrupts the inner blood-retinal barrier by induction of vascular endothelial growth factor in pericytes.

A high-throughput single-particle imaging platform for antibody characterization and a novel competition assay for therapeutic antibodies.

Of mice and Mike-An underappreciated Ebola virus disease model may have paved the road for future filovirology.

Host antiviral factors hijack furin to block SARS-CoV-2, ebola virus, and HIV-1 glycoproteins cleavage.

In vivo characterization of the novel ebolavirus Bombali virus suggests a low pathogenic potential for humans.

History and impact of the mouse-adapted Ebola virus model.

Mouse models of Ebola virus tolerance and lethality: characterization of CD-1 mice infected with wild-type, guinea pig-adapted, or mouse-adapted virus.

Maternal Immunization Using a Protein Subunit Vaccine Mediates Passive Immunity against Zaire ebolavirus in a Murine Model.

Traits, phylogeny and host cell receptors predict Ebolavirus host status among African mammals.

Multiplication of defective Ebola virus in a complementary permissive cell line.

A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates.

Similarities in the histological mouse model of early herpes simplex retinopathy with punctate inner choroidopathy and Ebola virus disease retinopathy.

Ebola virus L-VP35 structure.

Why doesn't Ebola virus cause pandemics like SARS-CoV-2?

Immunity-based Ebola optimization search algorithm for minimization of feature extraction with reduction in digital mammography using CNN models.

Activation of Toll-like receptor 4 by Ebola virus-shed glycoprotein is direct and requires the internal fusion loop but not glycosylation.

RNF185 regulates proteostasis in Ebolavirus infection by crosstalk between the calnexin cycle, ERAD, and reticulophagy.

Constructing, validating, and updating machine learning models to predict survival in children with Ebola Virus Disease.

First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study.

CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected Cells.

miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections.

Multimerization of Ebola GPΔmucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies.

Ebola virus infection induces a delayed type I IFN response in bystander cells and the shutdown of key liver genes in human iPSC-derived hepatocytes.

Enhanced In Vitro and In Vivo Potency of a T Cell Epitope in the Ebola Virus Glycoprotein Following Amino Acid Replacement at HLA-A*02:01 Binding Positions.

Post-Ebola Symptoms 7 Years After Infection: The Natural History of Long Ebola.

Evidence for Viral mRNA Export from Ebola Virus Inclusion Bodies by the Nuclear RNA Export Factor NXF1.

Lessons learned for surveillance system strengthening through capacity building and partnership engagement in post-Ebola Guinea, 2015-2019.

DR Congo rushes to contain resurgence of Ebola virus.

Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses.

The cytoplasmic tail substitution increases the assembly efficiency of Ebola virus glycoprotein on the budded virus of Bombyx mori nucleopolyhedrovirus.

What effect might border screening have on preventing importation of COVID-19 compared with other infections?: considering the additional effect of post-arrival isolation.

Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols.

Engineering Antiviral Agents via Surface Plasmon Resonance.

Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial.

Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease?

Adipocytes are susceptible to Ebola Virus infection.

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques.

Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus.

Why does viral RNA sometimes persist after recovery from acute infections?

3,4-Seco-Isopimarane Diterpenes from the Twigs and Leaves of Isodon Flavidus.

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.

Pandemic, Epidemic, Endemic: B Cell Repertoire Analysis Reveals Unique Anti-Viral Responses to SARS-CoV-2, Ebola and Respiratory Syncytial Virus.

Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region.

Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly.

TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction.

Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.

Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response.

A cryptic pocket in Ebola VP35 allosterically controls RNA binding.

Increasing International Collaboration and Networking Among High-level Isolation Units and Programs.

Viral haemorrhagic fevers and malaria co-infections among febrile patients seeking health care in Tanzania.

Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence of Aerosolised Ebola Virus in an Immune-Deficient Mouse.

Automated Laser-Transfer Synthesis of High-Density Microarrays for Infectious Disease Screening.

Antibody cocktail eliminates ebolaviruses.

Inferring the reproduction number using the renewal equation in heterogeneous epidemics.

Identification of novel Ebola virus inhibitors using biologically contained virus.

Functional interactomes of the Ebola virus polymerase identified by proximity proteomics in the context of viral replication.

Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses.

Findings and Implications From an Evaluation of the Gold Star Campaign in Post-Ebola Guinea: The Role of Gender and Education.

Spatial model of Ebola outbreaks contained by behavior change.

On the possibility of oscillating in the Ebola virus dynamics and investigating the effect of the lifetime of T lymphocytes.

Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the Congo.

Identification of novel chemical compounds targeting filovirus VP40-mediated particle production.

First laboratory confirmation and sequencing of Zaire ebolavirus in Uganda following two independent introductions of cases from the 10th Ebola Outbreak in the Democratic Republic of the Congo, June 2019.

Remdesivir and Human Milk: A Case Study.

"Is There Anything Else You Would Like to Add?": The Ethics of (Not) Addressing Research Participants' Top Concerns in Public Health Emergency Health Research.

Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors.

From viral evolution to spatial contagion: a biologically modulated Hawkes model.

Best practices of highly infectious decedent management: Consensus recommendations from an international expert workshop.

Cryo-EM analysis of Ebola virus nucleocapsid-like assembly.

The 2018-2020 Ebola Outbreak in the Democratic Republic of Congo: A Better Response Had Been Achieved Through Inter-State Coordination in Africa.

Registered Nurses' Perceptions After a Patient with Ebola Virus Disease Is Admitted to Their Hospital.

Ethical and sociocultural challenges in managing dead bodies during epidemics and natural disasters.

Structure, Process, and Outcomes of Liberian National Nursing and Midwifery Curricular Revisions.

Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model.

The Brief Case: A 6-Year-Old with Fever, Abdominal Pain, and Recent Travel to Sierra Leone.

Experts criticise WHO response to sex abuse allegations.

Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in Macaques.

[Flow cytometry evaluation of the rhesus monkey cellular immunity following the Zaire ebolavirus (Filoviridae; Ebolavirus: Zaire ebolavirus) experimental infection].

Marta Lado-Ebola, HIV, sexual health and more.

Modulation of immune response in Ebola virus disease.

Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant.

Enabling Artificial Intelligence for Genome Sequence Analysis of COVID-19 and Alike Viruses.

Conserved immunogenic peptides of Ebola glycoprotein elicit immune response in human peripheral blood mononuclear cells.

Delays in reporting and publishing trial results during pandemics: cross sectional analysis of 2009 H1N1, 2014 Ebola, and 2016 Zika clinical trials.

Pooled Analysis of the Accuracy of Xpert Ebola Assay for Diagnosing Ebola Virus Infection.

Ebola Virus IgG Seroprevalence in Southern Mali.

Retention of healthcare workers 1 year after recruitment and deployment in rural settings: an experience post-Ebola in five health districts in Guinea.

A multi-stage stochastic programming approach to epidemic resource allocation with equity considerations.

The Ferret as a Model for Filovirus Pathogenesis and Countermeasure Evaluation.

Early Experiences in the Integration of Non-communicable Diseases into Emergency Primary Health Care, Beni Region, Democratic Republic of the Congo.

Increased Likelihood of Detecting Ebola Virus RNA in Semen by Using Sample Pelleting.

Liberia's Community Health Assistant Program: Scale, Quality, and Resilience.

[eLearning approach for capacity strengthening of health professionals in Guinea: A post-Ebola experience].

[Ebola virus (Filoviridae: Ebolavirus: Zaire ebolavirus): fatal adaptation mutations].

What factors shape surgical access in West Africa? A qualitative study exploring patient and provider experiences of managing injuries in Sierra Leone.